Document Detail


Results of the Royal Marsden Hospital second soft tissue sarcoma schedule (STS II) chemotherapy regimen in the management of advanced sarcoma.
MedLine Citation:
PMID:  7000348     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Forty-eight patients with advanced soft tissue sarcoma were treated with a five-drug combination regimen consisting of vincristine, actinomycin D, and cyclophosphamide (Day 1) followed by doxorubicin and an infusion of methotrexate (Day 22). Thirty-seven of the 48 patients were fully evaluable. Of the 37 evaluable patients, two achieved a complete remission and three achieved a partial remission, with an overall response rate of 13.5%. These results compare unfavorably with previously reported series from this and other centers, and the regimen has now been superseded.
Authors:
B M Bryant; E Wiltshaw
Related Documents :
22808358 - Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicul...
22648558 - Effect of body mass index on the outcome of children with acute myeloid leukemia.
18851808 - Current concepts for management of soft tissue sarcomas of the extremities.
22904648 - Ipilimumab pharmacotherapy in patients with metastatic melanoma.
24778048 - The clinical impact of the lymph node ratio as a prognostic factor after resection of p...
17370788 - Effects of chemotherapy on patients with unresectable or metastatic adenocarcinoma of g...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Cancer treatment reports     Volume:  64     ISSN:  0361-5960     ISO Abbreviation:  Cancer Treat Rep     Publication Date:    1980 Apr-May
Date Detail:
Created Date:  1981-01-26     Completed Date:  1981-01-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7607107     Medline TA:  Cancer Treat Rep     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  689-92     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antineoplastic Agents / administration & dosage*
Clinical Trials as Topic
Cyclophosphamide / administration & dosage
Dactinomycin / administration & dosage
Doxorubicin / administration & dosage
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Male
Methotrexate / administration & dosage
Middle Aged
Sarcoma / drug therapy*,  mortality
Soft Tissue Neoplasms / drug therapy*,  mortality
Vincristine / administration & dosage
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 50-76-0/Dactinomycin; 57-22-7/Vincristine; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and p...
Next Document:  Tamoxifen: an overview of recent studies in the field of oncology.